NASDAQ:IMCC - Nasdaq - CA44969Q4060 - Common Stock - Currency: USD
NASDAQ:IMCC (5/9/2025, 8:00:54 PM)
1.65
-0.05 (-2.94%)
The current stock price of IMCC is 1.65 USD. In the past month the price increased by 25%. In the past year, price decreased by -61.59%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 53.38 | 696.37B | ||
JNJ | JOHNSON & JOHNSON | 15.35 | 371.06B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 18.9 | 291.96B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.08 | 214.69B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 18.16 | 209.49B | ||
MRK | MERCK & CO. INC. | 9.75 | 191.17B | ||
PFE | PFIZER INC | 6.94 | 126.36B | ||
SNY | SANOFI-ADR | 13.1 | 122.16B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 6.33 | 94.53B | ||
GSK | GSK PLC-SPON ADR | 6.72 | 74.10B | ||
ZTS | ZOETIS INC | 26.46 | 71.04B | ||
HLN | HALEON PLC-ADR | 22.38 | 48.43B |
IM Cannabis Corp. engages in the production and sale of medical cannabis products. The company employs 55 full-time employees The company went IPO on 2019-11-05. The firm's ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging proprietary data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel. In Germany, the Company operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The company offers four different product lines, leading with the Craft Collection which offers the highest quality Canadian craft cannabis flower. The firm's other product lines include Top-Shelf Collection, Signature Collection and Full Spectrum Extracts. The firm's brands include The WAGNERS, BLKMKT, LOT420, and The PICO collection (minis).
IM CANNABIS CORP
Kibbutz Glil Yam
TORONTO ONTARIO IL
CEO: Oren Shuster
Employees: 55
Phone: 14162564202
The current stock price of IMCC is 1.65 USD. The price decreased by -2.94% in the last trading session.
The exchange symbol of IM CANNABIS CORP is IMCC and it is listed on the Nasdaq exchange.
IMCC stock is listed on the Nasdaq exchange.
IM CANNABIS CORP (IMCC) has a market capitalization of 5.10M USD. This makes IMCC a Nano Cap stock.
IM CANNABIS CORP (IMCC) currently has 55 employees.
IM CANNABIS CORP (IMCC) has a support level at 1.5 and a resistance level at 1.7. Check the full technical report for a detailed analysis of IMCC support and resistance levels.
The Revenue of IM CANNABIS CORP (IMCC) is expected to grow by 41.23% in the next year. Check the estimates tab for more information on the IMCC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
IMCC does not pay a dividend.
IM CANNABIS CORP (IMCC) will report earnings on 2025-08-12.
IM CANNABIS CORP (IMCC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.43).
The outstanding short interest for IM CANNABIS CORP (IMCC) is 0.64% of its float. Check the ownership tab for more information on the IMCC short interest.
ChartMill assigns a technical rating of 1 / 10 to IMCC. When comparing the yearly performance of all stocks, IMCC is a bad performer in the overall market: 92.43% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to IMCC. IMCC may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months IMCC reported a non-GAAP Earnings per Share(EPS) of -2.43. The EPS decreased by -78.84% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -27.01% | ||
ROE | -201.89% | ||
Debt/Equity | 3.01 |
ChartMill assigns a Buy % Consensus number of 83% to IMCC. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 86.24% and a revenue growth 41.23% for IMCC